Literature DB >> 29321706

Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist.

Zeliha Tülek1, Cansu Polat1, Murat Kürtüncü2, Mefkure Eraksoy2.   

Abstract

INTRODUCTION: Multiple sclerosis (MS) is a disease that causes different symptoms in each attack and has an individual-specific course. Detailed questioning and recording of MS symptoms is important for developing a management plan for individual-specific symptoms. The present study was planned to evaluate the validity and reliability of the Turkish version of "Multiple Sclerosis-Related Symptom Checklist" (MS-RS), which has been developed for patients to personally follow-up the symptoms they experience.
METHODS: The study was conducted in the outpatient MS clinic of the Istanbul University Istanbul Faculty of Medicine between January and October 2013 and included a sample group of 148 patients who were aged >18 years, could easily communicate, had a definite diagnosis of MS, and had no other medical problems besides MS. The data were collected using patient information forms, including sociodemographic and MS-RS forms. To assess the linguistic validity, the Likert-type scale with 26 items was first applied to a group of 30 patients. Confirmatory factor analysis was used to test the construct validity. Furthermore, the correlation of the scale with the Expanded Disability Status Scale (EDSS), Hospital Anxiety and Depression Scale (HADS), Mini-Mental Status Evaluation (MMSE) scale, and Multiple Sclerosis Quality of Life Scale-54 (MSQL-54) was evaluated.
RESULTS: The scale comprised five factors with factor loading values between 0.39 and 0.86. The item-total correlation coefficients revealed values of 0.27-0.88. The Cronbach's alpha reliability coefficient for the whole scale was determined to be 0.89 and for the subscales to be 0.60-0.85. The test-retest analysis revealed no difference between the scale and its subscales in terms of invariance with time (p>0.05). Moreover, MS-RS was significantly correlated with EDSS, HADS, MMSE, and MSQL-54.
CONCLUSION: The Turkish version of MS-RS is a valid and reliable scale that can be used in the Turkish population.

Entities:  

Keywords:  Multiple sclerosis; multiple sclerosis-related symptom checklist; reliability; validity

Year:  2016        PMID: 29321706      PMCID: PMC5758076          DOI: 10.5152/npa.2016.16976

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  35 in total

1.  Self-reported severity among patients with multiple sclerosis in the U.S. and its association with health outcomes.

Authors:  Shaloo Gupta; Amir Goren; Amy L Phillips; Fernando Dangond; Michelle Stewart
Journal:  Mult Scler Relat Disord       Date:  2013-06-27       Impact factor: 4.339

2.  Anxiety, depression and fatigue at 5-year review following CNS demyelination.

Authors:  S Simpson; H Tan; P Otahal; B Taylor; A-L Ponsonby; R M Lucas; L Blizzard; P C Valery; J Lechner-Scott; C Shaw; D Williams; I van der Mei
Journal:  Acta Neurol Scand       Date:  2016-01-12       Impact factor: 3.209

Review 3.  The epidemiology of multiple sclerosis: insights to disease pathogenesis.

Authors:  Douglas S Goodin
Journal:  Handb Clin Neurol       Date:  2014

4.  Clutter management for individuals with multiple sclerosis.

Authors:  J Tamar Kalina
Journal:  Int J MS Care       Date:  2014

5.  Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society.

Authors:  T Henze; P Rieckmann; K V Toyka
Journal:  Eur Neurol       Date:  2006-09-08       Impact factor: 1.710

6.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

Review 7.  Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis.

Authors:  Pouria Heydarpour; Shayan Khoshkish; Shabnam Abtahi; Maziar Moradi-Lakeh; Mohammad Ali Sahraian
Journal:  Neuroepidemiology       Date:  2015-06-16       Impact factor: 3.282

8.  Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.

Authors:  Hina Garg; Steffani Bush; Eduard Gappmaier
Journal:  Int J MS Care       Date:  2016 Mar-Apr

9.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

10.  Symptoms, prevalence and impact of multiple sclerosis in younger patients: a multinational survey.

Authors:  Francesco Patti; Carlos Vila
Journal:  Neuroepidemiology       Date:  2014-05-07       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.